XMED iQ France BeNeLux SRL
XMED iQ France BeNeLux reported total assets of 653,917 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Sep 2026).
The score of XMED iQ France BeNeLux shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +408 % Total assets +852 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
XMED iQ France BeNeLux's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Sep 2026
- Year ended 31 Dec 2024filed on 28 Sep 2025
- Year ended 31 Dec 2023filed on 15 Oct 2024
- Year ended 31 Dec 2022filed on 27 Aug 2023
XMED iQ France BeNeLux's financial analysis
- Solvency7.6%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of XMED iQ France BeNeLux
XMED iQ France BeNeLux's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0776.368.501
- VAT number
- BE0776368501
- Peppol
- Registered · 0208:0776368501 · as of 12 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Oct 2021
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 28 Sep 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
XMED iQ France BeNeLux (SRL) has been based in Brussels since 2021, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 24,420 € and equity of 49,827 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to XMED iQ France BeNeLux
Companies in the same business, of comparable size and area, outside its group.
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- Takeda Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €86.4m
- Biogen Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €25.5m
- Meda Bright Wholesale of pharmaceutical and medical goods Brussels · balance sheet 469,972 €
- Novalab Wholesale of pharmaceutical and medical goods Uccle · balance sheet 113,734 €
- Futtitinni Wholesale of pharmaceutical and medical goods Uccle · balance sheet 129,363 €
- BIMEX Analytics Wholesale of pharmaceutical and medical goods Uccle · balance sheet 592,212 €
- Vervloet MSM Wholesale of pharmaceutical and medical goods Sint-Niklaas · balance sheet 189,219 €
Frequently asked questions about XMED iQ France BeNeLux
What is the revenue of XMED iQ France BeNeLux?
XMED iQ France BeNeLux files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of XMED iQ France BeNeLux?
In Belgium, the VAT number is the company number prefixed with BE: BE0776368501 for XMED iQ France BeNeLux, if the company is VAT-registered. Its company number (CBE) is 0776.368.501.
Where is the registered office of XMED iQ France BeNeLux?
According to the CBE register, the registered office of XMED iQ France BeNeLux is in 1000 Brussels.
What is the equity of XMED iQ France BeNeLux?
At the close of the 2025 financial year, the equity of XMED iQ France BeNeLux amounts to 49,827 €, a solvency of 7.6% of total assets.
Who manages XMED iQ France BeNeLux?
The register lists 2 active mandates at XMED iQ France BeNeLux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of XMED iQ France BeNeLux
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →